Page last updated: 2024-11-02

pentobarbital and Peritoneal Carcinomatosis

pentobarbital has been researched along with Peritoneal Carcinomatosis in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baserga, R1
Weiss, L1

Other Studies

1 other study available for pentobarbital and Peritoneal Carcinomatosis

ArticleYear
Inhibition of deoxyribonucleic acid synthesis by pentobarbital.
    Biochimica et biophysica acta, 1967, Sep-26, Volume: 145, Issue:2

    Topics: Animals; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Depression, Chemical; DNA, Neoplasm; Female; HeL

1967